CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Ionis Pharmaceuticals, Inc. - IONS CFD

50.65
0.66%
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.40
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 50.32
Open 50.13
1-Year Change 23.29%
Day's Range 50.03 - 50.89
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 24, 2024 50.65 0.42 0.84% 50.23 50.91 49.95
Jul 23, 2024 50.32 -0.10 -0.20% 50.42 51.12 49.17
Jul 22, 2024 50.53 2.13 4.40% 48.40 51.07 48.40
Jul 19, 2024 47.75 0.94 2.01% 46.81 48.96 46.81
Jul 18, 2024 47.15 -0.86 -1.79% 48.01 48.09 46.52
Jul 17, 2024 47.88 -1.11 -2.27% 48.99 49.49 47.58
Jul 16, 2024 49.79 0.62 1.26% 49.17 50.56 48.46
Jul 15, 2024 47.50 0.25 0.53% 47.25 47.94 46.61
Jul 12, 2024 47.89 1.34 2.88% 46.55 48.18 46.55
Jul 11, 2024 47.20 -1.29 -2.66% 48.49 49.38 47.03
Jul 10, 2024 47.79 0.66 1.40% 47.13 48.09 46.70
Jul 9, 2024 46.99 0.45 0.97% 46.54 47.17 46.49
Jul 8, 2024 47.19 0.99 2.14% 46.20 47.26 45.24
Jul 5, 2024 46.04 0.97 2.15% 45.07 46.26 44.86
Jul 3, 2024 45.37 1.46 3.32% 43.91 45.77 43.91
Jul 2, 2024 45.09 -0.96 -2.08% 46.05 47.14 44.72
Jul 1, 2024 47.04 -0.22 -0.47% 47.26 48.55 46.04
Jun 28, 2024 47.58 0.88 1.88% 46.70 47.66 46.70
Jun 27, 2024 47.17 -0.14 -0.30% 47.31 47.71 46.92
Jun 26, 2024 47.66 1.37 2.96% 46.29 47.77 46.27

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Ionis Pharmaceuticals Company profile

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; and Kynamro an oligonucleotide inhibitor for use in patients with homozygous familial hypercholesterolemia to reduce low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein. It is also developing inotersen, an antisense drug Ionis to treat patients with hereditary transthyretin amyloidosis; and volanesorsen, an antisense drug for the treatment of familial chylomicronemia syndrome and familial partial lipodystrophy. In addition, the company is developing drugs for various indications, such as cardiometabolic diseases caused by lipid disorders; cardiovascular disease, clotting disorders, and Alzheimer's and Parkinson's diseases; and acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington's disease. Ionis Pharmaceuticals, Inc. has a collaboration agreement with AstraZeneca to discover and develop antisense therapies for treating cardiovascular and metabolic diseases, and cancer; and Biogen Inc. to develop and commercialize therapies for neurological disorders, SMA, and neurodegenerative diseases. The company was formerly known as Isis Pharmaceuticals, Inc. and changed its name to Ionis Pharmaceuticals, Inc. in December 2015. Ionis Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Carlsbad, California.
Industry: Biotechnology & Medical Research (NEC)

2855 Gazelle Court
CARLSBAD
CALIFORNIA 92010
US

People also watch

US100

19,007.70 Price
-0.510% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

3,177.02 Price
-5.890% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Gold

2,371.72 Price
-0.970% 1D Chg, %
Long position overnight fee -0.0195%
Short position overnight fee 0.0112%
Overnight fee time 21:00 (UTC)
Spread 0.30

XRP/USD

0.61 Price
-3.190% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading